Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2007

01.07.2007 | Brief Report

Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE/C6 ELISA and Immunoblot

verfasst von: K. Riesbeck, B. Hammas

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Excerpt

The Borrelia burgdorferi sensu lato complex consists of eleven different species [1]. B. burgdorferi sensu stricto are isolated from patients both in North America and Europe, whereas B. garinii and B. afzelii are mainly found in Europe. The complete genome of B. burgdorferi has been sequenced and recent years a growing body of knowledge on important surface proteins has accumulated [2]. Borrelia Outer surface protein C (OspC) [3] and Vmp-like sequence expressed (VlsE) [4] are two plasmid encoded membrane proteins that both are immunodominant antigens. Furthermore, VlsE consists of one invariable region (IR6), which is extraordinary immunodominant [5, 6]. Other antigens that have been useful in serology are p39 and p83 [7]. Proteins that only are expressed in vivo are, for example, protein G, BBA36, and BB0323 with to date unknown functions, and finally the factor H binding protein Crasp3. …
Literatur
1.
Zurück zum Zitat Centers for Disease Control and Prevention (2004) Lyme Disease-United States 2001–2002. Morb Mortal Wkly Rep 53:365–369 Centers for Disease Control and Prevention (2004) Lyme Disease-United States 2001–2002. Morb Mortal Wkly Rep 53:365–369
2.
Zurück zum Zitat Rosa PA, Tilly K, Stewart PE (2005) The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol 3:129–143PubMedCrossRef Rosa PA, Tilly K, Stewart PE (2005) The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol 3:129–143PubMedCrossRef
3.
Zurück zum Zitat Padula SJ, Dias F, Sampieri A, Craven RB, Ryan RW (1994) Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J Clin Microbiol 32:1733–1738PubMed Padula SJ, Dias F, Sampieri A, Craven RB, Ryan RW (1994) Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J Clin Microbiol 32:1733–1738PubMed
4.
Zurück zum Zitat Sung SY, McDowell JV, Marconi RT (2001) Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes. J Bacteriol 183:5855–5861PubMedCrossRef Sung SY, McDowell JV, Marconi RT (2001) Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes. J Bacteriol 183:5855–5861PubMedCrossRef
5.
Zurück zum Zitat Lawrenz MB, Hardham JM, Owens RT et al (1999) Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 37:3997–4004PubMed Lawrenz MB, Hardham JM, Owens RT et al (1999) Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 37:3997–4004PubMed
6.
Zurück zum Zitat Philipp MT, Marques AR, Fawcett PT, Dally LG, Martin DS (2004) C6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis. J Clin Microbiol 41:4955–4960CrossRef Philipp MT, Marques AR, Fawcett PT, Dally LG, Martin DS (2004) C6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis. J Clin Microbiol 41:4955–4960CrossRef
7.
Zurück zum Zitat Hauser U, Lehnert G, Wilske B (1999) Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 37:2241–2247PubMed Hauser U, Lehnert G, Wilske B (1999) Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 37:2241–2247PubMed
8.
Zurück zum Zitat Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP (2005) Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18:484–509PubMedCrossRef Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP (2005) Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18:484–509PubMedCrossRef
9.
Zurück zum Zitat Centers for Disease Control and Prevention (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 44:590–591 Centers for Disease Control and Prevention (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 44:590–591
10.
Zurück zum Zitat Marangoni A, Sambri V, Accardo S et al (2006) A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin Vaccine Immunol 13:525–529PubMedCrossRef Marangoni A, Sambri V, Accardo S et al (2006) A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin Vaccine Immunol 13:525–529PubMedCrossRef
Metadaten
Titel
Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE/C6 ELISA and Immunoblot
verfasst von
K. Riesbeck
B. Hammas
Publikationsdatum
01.07.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2007
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0329-x

Weitere Artikel der Ausgabe 7/2007

European Journal of Clinical Microbiology & Infectious Diseases 7/2007 Zur Ausgabe

Announcement

Announcements

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.